Croda International Plc (LON:CRDA) Insider Steve Foots Acquires 5 Shares

Croda International Plc (LON:CRDA) insider Steve Foots acquired 5 shares of the stock in a transaction on Tuesday, July 15th. The shares were purchased at an average price of GBX 2,987 ($40.08) per share, with a total value of £149.35 ($200.42).

Steve Foots also recently made the following trade(s):

• On Monday, May 12th, Steve Foots acquired 5 shares of Croda International stock. The shares were purchased at an average price of GBX 3,196 ($42.89) per share, with a total value of £159.80 ($214.44).

Croda International Price Performance

CRDA stock opened at GBX 2,861 ($38.39) on Thursday. The stock has a market capitalization of £4.00 billion, a PE ratio of 24.58, a price-to-earnings-growth ratio of 1.40 and a beta of 0.74. The company’s 50-day moving average is GBX 3,047.81 and its 200-day moving average is GBX 3,068.44. The company has a debt-to-equity ratio of 30.90, a current ratio of 2.72 and a quick ratio of 2.25. Croda International Plc has a 1 year low of GBX 2,551 ($34.23) and a 1 year high of GBX 4,335 ($58.17).

Wall Street Analysts Forecast Growth

CRDA has been the subject of several research analyst reports. Citigroup lowered their price target on shares of Croda International from GBX 3,550 ($47.64) to GBX 3,300 ($44.28) and set a “neutral” rating for the company in a report on Tuesday, April 29th. Berenberg Bank reiterated a “buy” rating and set a GBX 3,800 ($50.99) price target on shares of Croda International in a report on Thursday, April 24th.

About Croda International

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.